1. Home
  2. EQPT vs ERAS Comparison

EQPT vs ERAS Comparison

Compare EQPT & ERAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EQPT

EquipmentShare.com Inc Common Stock

N/A

Current Price

$24.02

Market Cap

5.8B

Sector

N/A

ML Signal

N/A

Logo Erasca Inc.

ERAS

Erasca Inc.

HOLD

Current Price

$10.25

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EQPT
ERAS
Founded
2015
2018
Country
United States
United States
Employees
8206
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
5.5B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
EQPT
ERAS
Price
$24.02
$10.25
Analyst Decision
Buy
Strong Buy
Analyst Count
9
12
Target Price
$38.88
$14.25
AVG Volume (30 Days)
2.3M
8.6M
Earning Date
03-18-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
36.23
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$21.53
N/A
Revenue Next Year
$23.15
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.95
$1.06
52 Week High
$35.50
$24.28

Technical Indicators

Market Signals
Indicator
EQPT
ERAS
Relative Strength Index (RSI) 56.20 36.23
Support Level $18.58 $2.07
Resistance Level $25.89 $16.14
Average True Range (ATR) 1.88 0.88
MACD 0.55 -0.21
Stochastic Oscillator 66.56 59.45

Price Performance

Historical Comparison
EQPT
ERAS

About EQPT EquipmentShare.com Inc Common Stock

EquipmentShare.com Inc is a vertically integrated platform that combines proprietary technology, a connected equipment fleet, and a nationwide footprint to serve the construction industry. The company operates its business through the following reportable segments: Equipment Rental and Services Operations, comprised of recurring activity performed at full-service branch locations, such as equipment rentals and related services, and sales of parts, supplies, and maintenance services to construction contractors and others. Equipment Sales, sales of new or used equipment made at any of the branch locations and dealership sites, including equipment sales to participants in the OWN Program.

About ERAS Erasca Inc.

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Its focused RAS/MAPK pathway pipeline comprises modality-agnostic programs aligned with three therapeutic strategies of: targeting key upstream and downstream signaling nodes in the RAS/MAPK pathway; targeting RAS directly; and targeting escape routes that emerge in response to treatment. Its pipeline includes two clinical-stage programs (ERAS-0015, a pan-RAS molecular glue; and ERAS-4001, a pan-KRAS inhibitor), and ERAS-12, a discovery-stage program.

Share on Social Networks: